|
End-of-day quote
Shanghai S.E.
2026-10-09
|
5-day change | 1st Jan Change | ||
| 36.78 CNY | +1.71% |
|
+1.18% | -13.56% |
| Market Cap | 11.71B 1.75B 1.56B 1.45B 1.32B 2.49B 169B 2.5B 17.48B 6.85B 86.25B 6.56B 6.42B 277B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 9.1B 1.36B 1.21B 1.13B 1.03B 1.94B 131B 1.95B 13.58B 5.32B 67.03B 5.1B 4.99B 215B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | +1.71% | ||
| 1 week | +1.18% | ||
| Current month | +1.18% | ||
| 1 month | -3.34% | ||
| 3 months | -0.89% | ||
| 6 months | -12.80% | ||
| Current year | -13.56% |
| 1 week | 36.01 |  | 36.79 |
| 1 month | 35.46 | | 37.88 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 49.85 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 2014-11-19 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 2019-10-24 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 2015-01-07 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 2015-01-07 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 2015-01-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.71% | +1.18% | -22.91% | -4.68% | 1.75B | |
| +0.83% | +3.19% | +37.87% | +106.25% | 1,051B | |
| +1.93% | +2.11% | +36.82% | +64.90% | 630B | |
| +1.49% | +5.19% | +19.84% | +85.41% | 489B | |
| +2.26% | +0.90% | +66.40% | +39.33% | 359B | |
| +1.45% | +3.50% | +21.87% | +42.64% | 344B | |
| +1.17% | +2.37% | +11.71% | +35.14% | 272B | |
| +0.89% | +1.08% | -7.28% | +10.52% | 246B | |
| +1.82% | +2.94% | +40.43% | +52.78% | 224B | |
| +2.77% | +4.44% | +29.49% | +101.40% | 187B | |
| Average | +1.52% | +2.51% | +23.42% | +53.37% | 380.55B | |
| Weighted average by Cap. | +1.20% | +2.44% | +31.54% | +69.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 419M 374M 348M 317M 598M 40.55B 600M 4.19B 1.64B 20.68B 1.57B 1.54B 66.35B | 2.98B 445M 398M 370M 336M 635M 43.08B 638M 4.45B 1.74B 21.96B 1.67B 1.64B 70.48B |
| Net income | 1.05B 157M 140M 130M 119M 224M 15.19B 225M 1.57B 615M 7.74B 589M 577M 24.85B | 938M 140M 125M 116M 106M 200M 13.55B 201M 1.4B 549M 6.91B 526M 514M 22.17B |
| Net Debt | -2.35B -351M -314M -292M -265M -501M -33.98B -503M -3.51B -1.38B -17.32B -1.32B -1.29B -55.59B | -2.61B -389M -348M -324M -294M -556M -37.69B -558M -3.89B -1.53B -19.22B -1.46B -1.43B -61.67B |
Employees
671
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-09 | CN¥36.78 | +1.71% | 2,879,239 |
| 26-10-08 | CN¥36.16 | -0.52% | 2,241,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
